OVID - Ovid Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OVID is currently covered by 1 analysts with an average price target of $5.69. This is a potential upside of $5.07 (817.74%) from yesterday's end of day stock price of $0.62.

Ovid Therapeutics's activity chart (see below) currently has 24 price targets and 18 ratings on display. The stock rating distribution of OVID is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.4% with an average time for these price targets to be met of 79.25 days.

Highest price target for OVID is $3, Lowest price target is $1, average price target is $1.2.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Jun-2024. First documented stock forecast 09-Mar-2018.

Best performing analysts who are covering OVID - Ovid Therapeutics:

Yigal Nochomovitz Brian Abrahams Tyler Van Buren Charles Duncan

Currently out of the existing stock ratings of OVID, 4 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.2

$0.17 (16.50%)

$3.5

1 years 1 months 7 days ago
(18-Jun-2024)

9/16 (56.25%)

$0.41 (51.90%)

281

Buy

$4

$0.16 (4.17%)

$12

4 years 3 months 6 days ago
(20-Apr-2021)

1/3 (33.33%)

$3.94 (76.95%)

36

Buy

$5

4 years 4 months 22 days ago
(03-Mar-2021)

0/2 (0%)

$2.06 (70.07%)

Buy

$20

$16.53 (476.37%)

$20

6 years 11 months 16 days ago
(10-Aug-2018)

0/2 (0%)

$13.88 (226.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OVID (Ovid Therapeutics) average time for price targets to be met?

On average it took 79.25 days on average for the stock forecasts to be realized with a an average price target met ratio 22.4

Which analyst has the current highest performing score on OVID (Ovid Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the current lower performing score on OVID (Ovid Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?

Yigal Nochomovitz works at CITI and has 9 price targets and 8 ratings on OVID

Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?

Tyler Van Buren with highest potential upside - $16.53

Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?

Brian Abrahams with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?